Cahill Represents Debt Financing Sources in $2.4 Billion Buyout of Capsugel by KKR
Cahill represented Barclays Capital, Deutsche Bank Securities, UBS Investment Bank and Mizuho International plc. as joint book-running managers in the Rule 144A/Reg S Offering of €325,000,000 9.875% Senior Notes due 2019 by Capsugel FinanceCo S.C.A. to finance the acquisition of the Capsugel business unit from Pfizer Inc. by Kohlberg Kravis Roberts & Co.
Cahill also represented UBS AG, as administrative agent, and Barclays Capital, Deutsche Bank Securities, Mizuho Corporate Bank, and KKR Capital Markets, as lead arrangers, in connection with the $1,070,000,000 senior secured credit facilities, comprised of a $920,000,000 Term B loan and a $150,000,000 revolving credit facility for Capsugel in connection with financing the acquisition.